oxybutynin has been researched along with Complications, Pregnancy in 6 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A cost-effectiveness analysis was undertaken alongside the smoking, nicotine, and pregnancy trial to compare NRT patches plus behavioral support to behavioral support alone, for pregnant women who smoked." | 9.20 | Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). ( Coleman, T; Cooper, S; Essex, HN; Li, J; Parrott, S; Wu, Q, 2015) |
| "A cost-effectiveness analysis was undertaken alongside the smoking, nicotine, and pregnancy trial to compare NRT patches plus behavioral support to behavioral support alone, for pregnant women who smoked." | 5.20 | Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). ( Coleman, T; Cooper, S; Essex, HN; Li, J; Parrott, S; Wu, Q, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Galati, BM | 1 |
| Carter, EB | 1 |
| Perez, M | 1 |
| Russell, S | 1 |
| Nazeer, S | 1 |
| Raghuraman, N | 1 |
| Kelly, JC | 1 |
| Tanaka, S | 1 |
| Kanagawa, T | 1 |
| Momma, K | 1 |
| Hori, S | 1 |
| Satoh, H | 1 |
| Nagamatsu, T | 1 |
| Fujii, T | 1 |
| Kimura, T | 1 |
| Sawada, Y | 1 |
| Pollak, KI | 1 |
| Lyna, P | 1 |
| Bilheimer, AK | 1 |
| Gordon, KC | 1 |
| Peterson, BL | 1 |
| Gao, X | 1 |
| Swamy, GK | 1 |
| Denman, S | 1 |
| Gonzalez, A | 1 |
| Rocha, P | 1 |
| Fish, LJ | 1 |
| Essex, HN | 1 |
| Parrott, S | 1 |
| Wu, Q | 1 |
| Li, J | 1 |
| Cooper, S | 1 |
| Coleman, T | 1 |
| Esser, ES | 1 |
| Romanyuk, A | 1 |
| Vassilieva, EV | 1 |
| Jacob, J | 1 |
| Prausnitz, MR | 1 |
| Compans, RW | 1 |
| Skountzou, I | 1 |
| Clark, SM | 1 |
| Nakad, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking[NCT01040949] | 705 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxybutynin and Complications, Pregnancy
| Article | Year |
|---|---|
Pharmacotherapeutic management of nicotine dependence in pregnancy.
Topics: Female; Humans; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2011 |
2 trials available for oxybutynin and Complications, Pregnancy
| Article | Year |
|---|---|
Efficacy of a couple-based randomized controlled trial to help Latino fathers quit smoking during pregnancy and postpartum: the Parejas trial.
Topics: Adult; Fathers; Female; Hispanic or Latino; Humans; Male; Pamphlets; Postpartum Period; Pregnancy; P | 2015 |
Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
Topics: Adult; Behavior Therapy; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Health Promotion; H | 2015 |
3 other studies available for oxybutynin and Complications, Pregnancy
| Article | Year |
|---|---|
Buprenorphine Patch as a Bridge to Sublingual Treatment of Opioid Use Disorder in Pregnancy.
Topics: Administration, Sublingual; Adult; Buprenorphine; Female; Humans; Narcotic Antagonists; Opioid-Relat | 2021 |
Prediction of sustained fetal toxicity induced by ketoprofen based on PK/PD analysis using human placental perfusion and rat toxicity data.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Biomarkers, Pharmacological; Co | 2017 |
Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy.
Topics: Animals; Drug Carriers; Drug Liberation; Female; Humans; Immunization; Immunoglobulin G; Lethal Dose | 2016 |